2016: The Year of Diversity in Clinical Trials | FDA Voice

2016: The Year of Diversity in Clinical Trials | FDA Voice

2016: The Year of Diversity in Clinical Trials

By: Robert M. Califf, M.D.

Controlled clinical trials provide a critical base of evidence for evaluating whether a medical product is effective before the product is approved for marketing. One challenge that remains for FDA is ensuring that research participants … Continue reading →